To improve the efficacy, gene editing of tumor cells began in the late 1980s, involving the expression of certain immune-stimulating cytokines, granulocyte macrophage colony-stimulating factor (GM-CSF) being one of the most studied [760]. This evidence concerns the gene CSF2 and neoplasm.